significant reductions were observed in ldl-c (100.6 ± 4.3 mg/dl vs. 80.0 ± 3.7 mg/dl), the ldl:hdl ratio (2.0 ± 0.1 vs. 1.7 ± 0.1), fasting blood glucose (101.4 ± 7.5 mg/dl vs. 91.7 ± 3.4 mg/dl), fasting blood insulin (7.92 ± 0.80 μu/ml vs. 5.76 ± 0.59 μu/ml), homeostasis model assessment of insulin resistance (homa-ir) (2.06 ± 0.30 vs. 1.40 ± 0.21), systolic bp (110.7 ± 2.2 mm hg vs. 105.5 ± 1.7 mm hg), and body weight (74.1 ± 2.4 kg vs. 71.5 ± 2.3 kg) (all p < 0.05).